{
    "2021-03-25": [
        [
            {
                "time": "2020-12-31",
                "original_text": "贝达药业2020年度净利同比增163% 拟10派3.1元",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "2020年度",
                        "净利",
                        "同比增163%",
                        "10派3.1元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "贝达药业(300558.SZ)拟使用不超15亿元闲置自有资金购买理财产品",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "300558.SZ",
                        "闲置自有资金",
                        "购买理财产品",
                        "15亿元"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "贝达药业(300558.SZ)及子公司拟申请不超20亿元融资额度",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "300558.SZ",
                        "子公司",
                        "融资额度",
                        "20亿元"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "交卷！贝达药业：2020年度净利润约6.06亿元，同比增长162.70%",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "2020年度",
                        "净利润",
                        "6.06亿元",
                        "同比增长162.70%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "贝达药业：2020年净利同比增162.7% 拟10派3.1元",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "2020年",
                        "净利",
                        "同比增162.7%",
                        "10派3.1元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "贝达药业(300558.SZ)：2020年净利升162.7%至6.06亿元 拟10派3.1元",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "300558.SZ",
                        "2020年",
                        "净利",
                        "升162.7%",
                        "6.06亿元",
                        "10派3.1元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "贝达药业：2020年净利同比增长162.70% 拟10派3.1元",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "2020年",
                        "净利",
                        "同比增长162.70%",
                        "10派3.1元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-12-31",
                "original_text": "贝达药业：2020年净利润同比增长162.7%",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "2020年",
                        "净利润",
                        "同比增长162.7%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}